322 related articles for article (PubMed ID: 11319919)
21. Functional reconstitution of oxidase activity in X-linked chronic granulomatous disease by retrovirus-mediated gene transfer.
Zentilin L; Tafuro S; Grassi G; Garcia R; Ventura A; Baralle F; Falaschi A; Giacca M
Exp Cell Res; 1996 Jun; 225(2):257-67. PubMed ID: 8660913
[TBL] [Abstract][Full Text] [Related]
22. Increased levels of spliced RNA account for augmented expression from the MFG retroviral vector in hematopoietic cells.
Krall WJ; Skelton DC; Yu XJ; Riviere I; Lehn P; Mulligan RC; Kohn DB
Gene Ther; 1996 Jan; 3(1):37-48. PubMed ID: 8929910
[TBL] [Abstract][Full Text] [Related]
23. Use of bicistronic retroviral vectors encoding the LacZ gene together with a gene of interest: a method to select producer cells and follow transduced target cells.
Staal FJ; Bakker AQ; Verkuijlen M; van Oort E; Spits H
Cancer Gene Ther; 1996; 3(5):345-51. PubMed ID: 8894254
[TBL] [Abstract][Full Text] [Related]
24. Gene therapy for hematopoietic and immune disorders.
Kohn DB
Bone Marrow Transplant; 1996 Dec; 18 Suppl 3():S55-8. PubMed ID: 8971410
[TBL] [Abstract][Full Text] [Related]
25. Missense mutation in exon 7 of the common gamma chain gene causes a moderate form of X-linked combined immunodeficiency.
Schmalstieg FC; Leonard WJ; Noguchi M; Berg M; Rudloff HE; Denney RM; Dave SK; Brooks EG; Goldman AS
J Clin Invest; 1995 Mar; 95(3):1169-73. PubMed ID: 7883965
[TBL] [Abstract][Full Text] [Related]
26. T cell reconstitution by haploidentical BMT does not restore the diversification of the Ig heavy chain gene in patients with X-linked SCID.
Minegishi Y; Ishii N; Tsuchida M; Okawa H; Sugamura K; Yata J
Bone Marrow Transplant; 1995 Dec; 16(6):801-6. PubMed ID: 8750273
[TBL] [Abstract][Full Text] [Related]
27. Nonrandom X chromosome inactivation in natural killer cells from obligate carriers of X-linked severe combined immunodeficiency.
Wengler GS; Allen RC; Parolini O; Smith H; Conley ME
J Immunol; 1993 Jan; 150(2):700-4. PubMed ID: 8093460
[TBL] [Abstract][Full Text] [Related]
28. The murine interleukin-2 receptor gamma chain gene: organization, chromosomal localization and expression in the adult thymus.
DiSanto JP; Certain S; Wilson A; MacDonald HR; Avner P; Fischer A; de Saint Basile G
Eur J Immunol; 1994 Dec; 24(12):3014-8. PubMed ID: 7805729
[TBL] [Abstract][Full Text] [Related]
29. Retrovirus-mediated transfer of the human alpha-L-iduronidase cDNA into human hematopoietic progenitor cells leads to correction in trans of Hurler fibroblasts.
Huang MM; Wong A; Yu X; Kakkis E; Kohn DB
Gene Ther; 1997 Nov; 4(11):1150-9. PubMed ID: 9425437
[TBL] [Abstract][Full Text] [Related]
30. Transmissibility of murine stem cell virus-based retroviral vectors carrying both interleukin-12 cDNAs and a third gene: implications for immune gene therapy.
Lieu FH; Hawley TS; Fong AZ; Hawley RG
Cancer Gene Ther; 1997; 4(3):167-75. PubMed ID: 9171935
[TBL] [Abstract][Full Text] [Related]
31. CAG repeat mutation in the mouse IL-2 gene enables concurrent assessment of T- and B-cell-specific gene expression by northern analysis.
Szebeni J; Sykes M
Exp Clin Immunogenet; 1996; 13(2):117-9. PubMed ID: 9063704
[TBL] [Abstract][Full Text] [Related]
32. Constitutive systemic expression of IL-1Ra or soluble TNF receptor by genetically modified hematopoietic cells suppresses LPS induction of IL-6 and IL-10.
Doughty LA; Patrene KD; Evans CH; Boggs SS; Robbins PD
Gene Ther; 1997 Mar; 4(3):252-7. PubMed ID: 9135739
[TBL] [Abstract][Full Text] [Related]
33. Patterns of X chromosome inactivation in haematopoietic cells of female carriers of X linked severe combined immunodeficiency.
Hendriks RW; Kraakman ME; Schuurman RK
Immunodeficiency; 1993; 4(1-4):263-5. PubMed ID: 8167715
[TBL] [Abstract][Full Text] [Related]
34. Retroviral marking of canine bone marrow: long-term, high-level expression of human interleukin-2 receptor common gamma chain in canine lymphocytes.
Whitwam T; Haskins ME; Henthorn PS; Kraszewski JN; Kleiman SE; Seidel NE; Bodine DM; Puck JM
Blood; 1998 Sep; 92(5):1565-75. PubMed ID: 9716584
[TBL] [Abstract][Full Text] [Related]
35. [Gene therapy for hereditary immunodeficiencies].
Fischer A; de Saint-Basile G; Disanto JP; Hacein-Bey S; Sharara L; Cavazzana-Calvo M
C R Seances Soc Biol Fil; 1996; 190(1):77-93. PubMed ID: 8881271
[TBL] [Abstract][Full Text] [Related]
36. Impairment of ligand binding and growth signaling of mutant IL-2 receptor gamma-chains in patients with X-linked severe combined immunodeficiency.
Ishii N; Asao H; Kimura Y; Takeshita T; Nakamura M; Tsuchiya S; Konno T; Maeda M; Uchiyama T; Sugamura K
J Immunol; 1994 Aug; 153(3):1310-7. PubMed ID: 8027558
[TBL] [Abstract][Full Text] [Related]
37. [Gene therapy for adenosine deaminase deficiency].
Sakiyama Y
Hokkaido Igaku Zasshi; 1996 Jan; 71(1):27-32. PubMed ID: 8727372
[TBL] [Abstract][Full Text] [Related]
38. The molecular basis of X-linked severe combined immunodeficiency: defective cytokine receptor signaling.
Leonard WJ
Annu Rev Med; 1996; 47():229-39. PubMed ID: 8712778
[TBL] [Abstract][Full Text] [Related]
39. Mutations in the gene for the common gamma chain (gammac) in X-linked severe combined immunodeficiency.
Fugmann SD; Müller S; Friedrich W; Bartram CR; Schwarz K
Hum Genet; 1998 Dec; 103(6):730-1. PubMed ID: 9921912
[TBL] [Abstract][Full Text] [Related]
40. The interleukin-2 receptor gamma chain: its role in the multiple cytokine receptor complexes and T cell development in XSCID.
Sugamura K; Asao H; Kondo M; Tanaka N; Ishii N; Ohbo K; Nakamura M; Takeshita T
Annu Rev Immunol; 1996; 14():179-205. PubMed ID: 8717512
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
